Skip to main content

Table 3 The ROX, mROX, ROX-HR, and mROX-HR indices predict HFNC success

From: Prediction of high-flow nasal cannula outcomes at the early phase using the modified respiratory rate oxygenation index

 

HFNC-success

(n = 51)

HFNC-failure

(n = 24)

p value

OR

value

95% CI

Baseline ROX [M(P25, P75)]

7.5 (6.0–10.6)

7.4 (5.4–8.4)

0.061

1.968

0.970–3.994

Baseline mROX [M(P25, P75)]

6.1 (4.3–9.0)

5.2 (4.0–6.5)

0.012

2.631

1.233–5.613

Baseline ROX-HR [M(P25, P75)]

7.6 (5.3–11.7)

6.0 (5.0–7.3)

0.013

3.013

1.259–7.210

Baseline mROX-HR [M(P25, P75)]

6.8 (4.2–9.8)

4.2 (3.4–5.7)

0.005

3.984

1.526–10.402

2 h ROX [mean ± SD]

8.3 ± 2.5

5.4 ± 2.3

0.001

5.954

2.434–14.613

2 h mROX [M(P25, P75)]

8.7 (6.0–12)

3.7 (2.6–5.5)

0.001

10.816

3.373–34.689

2 h ROX-HR [mean ± SD]

8.9 ± 3.7

4.9 ± 2.6

0.001

8.696

2.797–27.038

2 h mROX-HR [M(P25, P75)]

8.9 (5.8–12.6)

3.6 (2.3–4.1)

0.001

15.039

3.758–60.190

  1. Annotation: ROX, SpO2 /FiO2 (%) to RR (breaths/min); mROX, PaO2/FiO2(%) to RR(breaths/min); ROX-HR,ROX /HR*100; mROX-HR, mROX/HR*100; OR, odds ratio; CI, Confidence interval